🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Get your abstracts in ! This will be a memorable meeting !

"No one can whistle a symphony. It takes a whole orchestra to play it." Emory Skull Base Surgery 2023 course is ended. Great experience and exceptional teamwork. Alejandra Rodas, MD Edoardo Porto, MD Erion Jr de Andrade Manu Revuelta, MD, PhD Youssef Zohdy, MD Gustavo Pradilla Tomas Garzon-Muvdi

Skull Base Course 2023 wrap-up! Kudos to the incredible speakers, participants, and organizing team for making this a transformative learning experience! ✅ Gustavo Pradilla Tomas Garzon-Muvdi Edoardo Porto, MD Alejandra Rodas, MD Manu Revuelta, MD, PhD Leonardo Tariciotti, M.D. Biren Patel

Congrats to our Emory Neurosurgery 2024 incoming class. We are excited to have you join us.

So saddened to learn today that #neurosurgery lost (1 week ago) one of its pioneers in #skullbase & #cerebrovascular surgery, #TakanoriFukushima. He was the consummate innovative naturally skilled neurosurgical artist who exuded passion, perfected his craft & inspired legions😥

In the ENRICH trial of minimally invasive cerebral hematoma removal within 24 hours after onset of hemorrhage, functional outcomes were better with surgery than with medical treatment, particularly among patients with lobar hemorrhages. Full trial results: nej.md/3VPYggf

Editorial: New Hope for Adults with Lobar Intracerebral Hemorrhage nej.md/49uI0ob

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage NEJM nejm.org/doi/full/10.10…. Congratulations to the Emory School of Medicine investigators that designed and led this important trial Emory SOM at Grady Hospital Emory Health

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage | New England Journal of Medicine nejm.org/doi/full/10.10…

Congrats to ⁦Gustavo Pradilla⁩ and all #ENRICH investigators. Big day in #neurosurgery with ⁦Emory Healthcare⁩ ⁦⁦Emory Neurosurgery⁩ leading the way! ⁦NEJM⁩ ⁦CNS⁩ ⁦CV Section⁩ ⁦AANS⁩ ⁦SNIS Info⁩ nejm.org/doi/full/10.10…

Major RCT: ENRICH minimally invasive cerebral hematoma remova 24 hours after onset, functional outcomes better w surgery than medical treatment, particularly among patients with lobar hemorrhages. Great work Gustavo Pradilla & co. Thanks for including us: nej.md/3VPYggf

Groundbreaking results from a 6-year clinical trial investigating treatment for hemorrhagic strokes, led by Emory Neurosurgery, show the minimally invasive approach under study is safe and superior to the current standard of care. news.emory.edu/stories/2024/0…

USC Neurosurgery was thrilled to be an initial site for the #ENRICH trial just published in NEJM. Congrats to my friend Gustavo Pradilla and Emory Neurosurgery! #Neurosurgery #Stroke

Through the ENRICH Trial Emory Neurosurgery gives hope to patients suffering from hemorrhagic stroke. Our surgeons combine forces with NICONeuroCorp & Synaptive Medical for a promising surgical treatment on this week’s episode of YourFantasticMind. See you on 5/15 at 7pm on GPB.

instagram.com/reel/C6-KT24tl…

The Marcus Foundation makes major $25.9 million award to advance lifesaving stroke research at Emory and Grady news.emory.edu/stories/2024/0…

Save the date (and your spot) for the Emory 2025 skull base anatomy course. 🧠 see you there. Gustavo Pradilla Tomas Garzon-Muvdi Emory Neurosurgery Emory Skull Base Surgery Emory University

#ONSNew Biportal Endoscopic TransOrbital and transMaxillary Approach to the Cranio-Orbital Region and Middle Cranial Fossa: A Preliminary Analysis of Maneuverability bit.ly/4aIb2CY by Leonardo Tariciotti, M.D. et al Emory School of Medicine Olabisi Sanusi MD, FAANS CNS

No better way to avoid complications than learning from each other. Day 1 CNS Tumor Complication Course - great success with incredible engagement! #Neurosurgery Costas Hadjipanayis Shawn Hervey-Jumper Christopher P. Cifarelli MD, PhD, MMM Gustavo Pradilla Penn Neurosurgery NS Tumor Section Ohio State Neurosurgery Residency Daniel Kreatsoulas, MD

We have enrolled our 1st patient into the REACH clinical trial led by Gustavo Pradilla Dr. Gustavo Pradilla. This is the 1st study to investigate the use of minimally invasive parafascicular surgery for deep ICH, particularly within anterior basal ganglia. #neurosurgery #REACH